Published in Orv Hetil on November 08, 1970
Classes and subclasses of rat immunoglobulins: interaction with the complement system and with staphylococcal protein A. Immunochemistry (1978) 2.06
Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects. Eur J Clin Invest (2001) 1.66
The role of C3 in the immune response. Immunol Today (1991) 1.25
A marked drop in the incidence of the null allele of the B gene of the fourth component of complement (C4B*Q0) in elderly subjects: C4B*Q0 as a probable negative selection factor for survival. Hum Genet (1991) 1.08
Renal actinomycosis associated with bilateral necrosing renal papillitis. Int Urol Nephrol (1980) 1.07
Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study. J Hum Hypertens (2006) 1.07
Immunogenicity of antigen complexed with antibody. I. Role of different isotypes. Immunology (1982) 1.03
Functionally active C1 on the surface of human peripheral lymphocytes: its role in the complement-mediated inhibition of the Fc receptor of B lymphocytes. Clin Immunol Immunopathol (1976) 1.01
HIV and human complement: mechanisms of interaction and biological implication. Immunol Today (1993) 1.01
Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1. Immunology (1978) 0.98
The effect of immune complex composition on complement activation and complement dependent complex release. Immunochemistry (1978) 0.97
Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability. Int Immunol (1999) 0.97
High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin Exp Rheumatol (2002) 0.97
Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema. Eur J Gastroenterol Hepatol (2001) 0.97
Defensins purified from human granulocytes bind C1q and activate the classical complement pathway like the transmembrane glycoprotein gp41 of HIV-1. Mol Immunol (1997) 0.96
Classes and subclasses of rat antibodies: reaction with the antigen and interaction of the complex with the complement system. Immunology (1981) 0.96
The heterogeneity of Fc receptors on human peripheral mononuclear blood cells. Immunology (1979) 0.96
Interaction of C3 and C3b with immunoglobulin G. Mol Immunol (1983) 0.95
Studies on the mechanism of complement-mediated inhibition of antibody binding to HIV gp41. Clin Exp Immunol (1993) 0.94
Effect of angiotensin II on macrophage functions. Immunology (1983) 0.94
Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection. AIDS (1997) 0.93
Evaluation of different methods for detecting circulating immune complexes. An inter-laboratory study. J Immunol Methods (1980) 0.92
Effect of soluble immune complexes of Fc and C3 receptor-dependent phagocytosis by human monocytes. Immunology (1981) 0.92
Immunological alterations in anti-HTLV-III negative haemophiliacs and homosexual men in Hungary. Immunol Lett (1985) 0.91
Isolation and characterization of Fc-receptors shed from human peripheral mononuclear cells. Immunology (1978) 0.91
Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection. AIDS (1991) 0.91
Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema. Lancet (2001) 0.90
Activation of the complement system during infections due to gram-negative bacteria. Clin Immunol Immunopathol (1976) 0.90
Association of polymorphisms and allelic combinations in the tumour necrosis factor-alpha-complement MHC region with coronary artery disease. J Med Genet (2002) 0.89
Strong correlation between the complement-mediated antibody-dependent enhancement of HIV-1 infection and plasma viral load. AIDS (1999) 0.89
Association between early onset and organ manifestations of systemic lupus erythematosus (SLE) and a down-regulating promoter polymorphism in the MBL2 gene. Clin Immunol (2007) 0.88
Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection. Z Gastroenterol (1999) 0.88
Studies on the occurrence of circulating immune complexes in vascular diseases. Atherosclerosis (1978) 0.87
Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality. Clin Exp Immunol (2007) 0.87
Reduced lymphocyte activation in repeatedly inflamed human tonsils. Acta Otolaryngol (1980) 0.87
The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures. J Oral Maxillofac Surg (1999) 0.87
Low activity of the classical complement pathway predicts short survival of patients with chronic lymphocytic leukaemia. Clin Exp Immunol (1995) 0.86
A 60 kD heat-shock protein-like molecule interacts with the HIV transmembrane glycoprotein gp41. Mol Immunol (1999) 0.86
Sex hormones in hereditary angioneurotic oedema. Clin Endocrinol (Oxf) (2004) 0.86
Usefulness of densitometry in typing of human complement component C4. Immunogenetics (1989) 0.85
Epistatic effects of genes encoding immunoglobulin GM allotypes and interleukin-6 on the production of autoantibodies to 60- and 65-kDa heat-shock proteins. Genes Immun (2004) 0.85
Depressed classical complement pathway activities in chronic lymphocytic leukaemia. Clin Exp Immunol (1985) 0.85
Frequencies of certain complement protein alleles and serum levels of anti-heat-shock protein antibodies in cerebrovascular diseases. Stroke (2000) 0.84
The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease. Clin Chim Acta (2001) 0.84
BSA-anti-BSA immune complexes formed in the presence of human complement do not bind to autologous red blood cells. Immunology (1988) 0.84
The severity of clinical symptoms in ragweed-allergic patients is related to the extent of ragweed-induced complement activation in their sera. Allergy (1997) 0.84
Electronmicroscopic observations on the antigen receptors in the tonsillar tissue. Acta Biol Acad Sci Hung (1972) 0.84
High level of anticholesterol antibodies (ACHA) in HIV patients. Normalization of serum ACHA concentration after introduction of HAART. Immunobiology (2001) 0.84
Complement activation decreases the ability of HIV transmembrane envelope protein to bind to specific antibody. AIDS (1992) 0.84
Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases. Immunol Lett (2001) 0.84
FN-C1q and C1 INH C1r-C1s complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia. Immunol Lett (1989) 0.84
Evidences proving the intercalation hypothesis of the C-mediated complex release activity (CRA). Immunochemistry (1978) 0.84
Inhibition of the complement activation by an adrenal androgen, dehydroepiandrosterone. Complement (1984) 0.83
Angiooedema due to acquired deficiency of C1-esterase inhibitor associated with leucocytoclastic vasculitis. Acta Derm Venereol (2001) 0.83
Free and complexed anti-lipoprotein antibodies in vascular diseases. Atherosclerosis (1983) 0.83
Study of the immune complex precipitation-inhibiting capacity of sera of patients with chronic lymphocytic leukaemia. Diagn Clin Immunol (1987) 0.83
Study of the interaction between monoclonal IgM proteins and the complement system. Immunochemistry (1976) 0.83
C1 and C4 abnormalities in chronic lymphocytic leukaemia and their significance. Immunol Lett (1987) 0.83
Studies on the mechanism of the complement-mediated inhibition of the Fc and C3 receptors of B lymphocytes. Clin Immunol Immunopathol (1977) 0.83
Regulation of Fc mu receptor-mediated functions of resident and provoked peritoneal macrophages. Immunobiology (1984) 0.83
Safety aspects of intravenous immunoglobulins. Immunol Invest (1988) 0.83
Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1. Immunology (1995) 0.83
Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia. Clin Exp Immunol (2012) 0.83
Coincidence of hereditary angioedema (HAE) with Crohn's disease. Immunol Invest (1999) 0.82
Changes in the acute phase complement component and IL-6 levels in patients with chronic hepatitis C receiving interferon alpha-2b. Immunol Lett (2000) 0.82
Antibody production of toils. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1970) 0.82
Activation of the classical complement pathway by homogeneous anti-SIII antibody bound to bivalent or trivalent oligosaccharide antigens. Mol Immunol (1979) 0.82
Transport of mast cells by the blood circulation. Experientia (1969) 0.82
Long-term cultivation of lymph node fragments and cells of hyperimmunized rabbits. Life Sci (1968) 0.82
Th1 and Th2 cell responses of type 1 diabetes patients and healthy controls to human heat-shock protein 60 peptides AA437-460 and AA394-408. Inflamm Res (2005) 0.82
Danazol therapy for hereditary angio-oedema in children. Lancet (1999) 0.82
Cytokine regulation of the acute-phase protein levels in multiple myeloma. Eur J Clin Invest (1998) 0.82
Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus. Immunol Lett (2002) 0.82
The control of cardiolipin and lecithin products with the 50 percent hemolysis method. Z Immunitatsforsch Allerg Klin Immunol (1968) 0.82
Tonsils and lympho-epithelial structures in the pharynx as immuno-barriers. Acta Otolaryngol (1987) 0.82
Mannan-binding lectin serum concentrations in HIV-infected patients are influenced by the stage of disease. Immunol Lett (1997) 0.81
Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients. Scand J Immunol (1995) 0.81
Human anti-60 kD heat shock protein autoantibodies are characterized by basic features of natural autoantibodies. Acta Physiol Hung (2010) 0.81
Evaluation of different methods for detecting circulating immune complexes. Studies in patients with lung cancer. J Immunol Methods (1981) 0.81
Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis. Clin Exp Immunol (2013) 0.81
Complement activating antibodies against the human 60 kDa heat shock protein as a new independent family risk factor of coronary heart disease. Eur J Clin Invest (2002) 0.81
Serial measurement of circulating immune complexes in myocardial infarction. Br Heart J (1981) 0.81
Further investigations into the immunological role of tonsils. Acta Otolaryngol (1972) 0.80
[Submucous chordectomy as a glottis-enlarging operation]. HNO (1965) 0.80
Interactions of radio-detoxified Escherichia coli endotoxin preparations with the complement system. Infect Immun (1977) 0.80
Usefulness of detection of complement activation products in evaluating SLE activity. Lupus (2000) 0.80
Anti-cholesterol antibodies (ACHA) in patients with different atherosclerotic vascular diseases and healthy individuals. Characterization of human ACHA. Atherosclerosis (2001) 0.80
High prevalence of IgG and IgA antibodies to 19-kDa Helicobacter pylori-associated lipoprotein in chronic urticaria. Allergy (2003) 0.80
Acquired angioedema associated with chronic hepatitis C. J Allergy Clin Immunol (1999) 0.80
Complement activation in the nasal mucosa following nasal ragweed-allergen challenge. Pediatr Allergy Immunol (2001) 0.80
Appearance of covalently bound antigen in immune complexes formed during the activation of complement. J Immunol Methods (1984) 0.80
Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures. Clin Immunol (2001) 0.79
Depressed activation of the lectin pathway of complement in hereditary angioedema. Clin Exp Immunol (2008) 0.79
Comparative study of the complement-activating and specific IgE-binding properties of ragweed pollen allergen. Clin Exp Immunol (1997) 0.79
Inhibitory effect of C3b on rosette formation of peripheral blood mononuclear cells with mouse erythrocytes. Clin Exp Immunol (1982) 0.79
Role of C1 in the complement activating effect of Pseudomonas aeruginosa lipopolysaccharide preparations. Acta Microbiol Acad Sci Hung (1976) 0.79
C1-inhibitor autoantibodies in SLE. Lupus (2010) 0.79
Patients with CLL and hypocomplementaemia have an impaired serum bactericidal activity against the Salmonella minnesota Re mutant. Complement (1988) 0.79
Ragweed allergy: correlation between skin reactivity and in vitro complement activation. Immunol Lett (1998) 0.79